What the Cursor-Tracking Result Added to the Cannabis Attention Trial

The cannabis trial measured how far a cursor wandered from a moving target while participants also responded to peripheral signals. This tracking measure supplied information that a simple total of correct answers would miss.

A divided task rather than a single reaction

The Divided Attention Task required participants to follow a horizontally moving central stimulus with a mouse cursor and identify peripheral stimuli on the screen. The study recorded distance from the central target, peripheral detections and response timing.

Seventeen adults who had not used cannabis in the prior month completed the smoked and vaporized cannabis conditions. The nominal THC doses were 0, 10 and 25 mg in a crossover experiment.

Distance increased under the tested vaporized conditions

The authors reported significant effects on the distance measure after both active vaporized doses relative to placebo. At 10 mg, the reported peak change from baseline averaged 17.8 pixels after vaporization and 4.0 pixels after smoking; this route comparison was significant.

The unit is pixels on that task. It is not centimeters of vehicle lane movement or a measured increase in crash probability. Nor should a significant tracking result be substituted for a statement that every peripheral-detection or response-time endpoint changed.

Why the endpoint definition matters

A performance claim should name the task component that changed and the condition used for comparison. The study supports a specific laboratory tracking deficit, with limits from its small infrequent-user sample and administration procedure. Its companion pharmacokinetic report uses the same participants. The corrected table title identifies peak changes rather than simultaneous deficits at one universal time point.

Related analysis: the fixed-dose smoked and vaporized cannabis comparison.

Research cited

Spindle and colleagues (2018), Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial. DOI: 10.1001/jamanetworkopen.2018.4841.

Published correction concerning the table title.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Hundreds of Plasma Specimens Still Came From Six THC Participants

The study’s 264 plasma specimens did not represent 264 independent cannabis users. Repeated sampling increased information about each participant’s profile while leaving the human sample small. The denominator depended on the question The intensive inpatient study enrolled six established cannabis users and repeatedly measured cannabinoids during and after oral dronabinol…

Spread the love

Read Article: Hundreds of Plasma Specimens Still Came From Six THC Participants

Metabolite Ratios Rose During Repeated Oral THC While Parent THC Did Not Accumulate Similarly

During repeated dosing, 11-hydroxy-THC and THC-COOH increased over time without the same accumulation pattern for parent THC. A stable parent profile did not mean all measured cannabinoid exposure remained stable. The analytes followed different courses The six-person plasma study compared repeated oral dosing with measurements associated with cannabis use before…

Spread the love

Read Article: Metabolite Ratios Rose During Repeated Oral THC While Parent THC Did Not Accumulate Similarly

Repeated Oral THC Increased Daily Dose by Changing Administration Frequency

The intensive oral-THC regimen repeatedly used 20 mg capsules while shortening the intervals between administrations. A higher daily total did not mean every individual capsule dose became larger. The schedule defined exposure Six daily cannabis users received dronabinol at increasing frequency, with intervals described as every four to eight hours…

Spread the love

Read Article: Repeated Oral THC Increased Daily Dose by Changing Administration Frequency

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us